Literature DB >> 7535053

Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N.

Y Xu1, D Wellner, D A Scheinberg.   

Abstract

Aminopeptidase N (EC 3.4.11.2) is an important enzyme that is involved in the degradation of regulatory peptides including enkephalins. We report here that purified and native membrane-bound aminopeptidase N will sequentially and completely hydrolyze both Leu-enkephalin and Met-enkephalin from the amino terminus. Both purified pig aminopeptidase N and the enzyme on live HL60 cells displayed similar Km values for enkephalin. The naturally occurring neuropeptides substance P and bradykinin, and the morphine agonist, morphiceptin, were not hydrolyzed by aminopeptidase N and each inhibited the enzymatic activity. Each of these peptides contains a proline at the second residue. The Ki values for substance P (0.44 microM), bradykinin (9.4 microM), and morphiceptin (169 microM) were obtained with the enzyme on live HL60 cells. The values for the purified enzyme from pig were similar. The potent inhibition of aminopeptidase N by substance P and bradykinin suggests that these peptides may be natural inhibitors of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535053     DOI: 10.1006/bbrc.1995.1390

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.

Authors:  Liliana Guzman-Rojas; Roberto Rangel; Ahmad Salameh; Julianna K Edwards; Eleonora Dondossola; Yun-Gon Kim; Alan Saghatelian; Ricardo J Giordano; Mikhail G Kolonin; Fernanda I Staquicini; Erkki Koivunen; Richard L Sidman; Wadih Arap; Renata Pasqualini
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.

Authors:  A Kehlen; B Göhring; J Langner; D Riemann
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 3.  CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.

Authors:  Chenyang Lu; Mohammad A Amin; David A Fox
Journal:  J Immunol       Date:  2020-01-01       Impact factor: 5.422

4.  The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing.

Authors:  Alan H M Wong; Dongxia Zhou; James M Rini
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

5.  Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.

Authors:  Anne Wisner; Evelyne Dufour; Michaël Messaoudi; Amine Nejdi; Audrey Marcel; Marie-Noelle Ungeheuer; Catherine Rougeot
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

6.  Structural basis for multifunctional roles of mammalian aminopeptidase N.

Authors:  Lang Chen; Yi-Lun Lin; Guiqing Peng; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

7.  Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats.

Authors:  L Zambotti-Villela; S C Yamasaki; J S Villarroel; R F Alponti; P F Silveira
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

8.  Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides.

Authors:  Roman M Janas; Jerzy Socha; Jadwiga Janas; Krzysztof Warnawin
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

9.  Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN).

Authors:  Isel Pascual; Pedro A Valiente; Gabriela García; Mario E Valdés-Tresanco; Yarini Arrebola; Lisset Díaz; Lotfi Bounaadja; Rosa María Uribe; Mae Chappé Pacheco; Isabelle Florent; Jean-Louis Charli
Journal:  Biochimie       Date:  2017-09-28       Impact factor: 4.079

Review 10.  The moonlighting enzyme CD13: old and new functions to target.

Authors:  Paola Mina-Osorio
Journal:  Trends Mol Med       Date:  2008-07-05       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.